CTRI/2023/02/049424已完成2 期
Efficacy and safety of Rosuvastatin as an add on therapy in patients of chronic plaque psoriasis: a non-randomized, assessor blind, controlled clinical trial - Ros P2 Trial
Pt BD Sharma PGIMS Rohtak0 个研究点目标入组 48 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Patients having Chronic Plaque Psoriasis with Body surface area involvement of 10 percent or greater
- •2)Patients who are willing to give written informed consent
排除标准
- •1)Patients with present or past history of clinical atherosclerotic cardiovascular disease
- •2)Patients having deranged Liver Tunction test(LFT)/ Active liver disease(ALD)
- •3)Patients having clinical features suggestive of myopathy
- •4)Patients having known allergy to statins
- •5)Patients who are already on statins
- •6)Pregnancy and lactation
研究者
相似试验
招募中
4 期
Efficacy and safety of rosuvastatin combined with Shouhui Tongbian capsule in the treatment of dyslipidemia: a prospective, single-center, open, randomized controlled studyDyslipidemiaITMCTR2100004388Beijing Friendship Hospital Affiliated to Capital Medical University
已完成
3 期
The assessment of effect of Rosuvastatin use in venous thromboembolismVenous thromboembolism includes deep vein thrombosis and pulmonary embolism.venous embolism and thrombosisCode I82IRCT20210416050990N1Shahid Beheshti University of Medical Sciences220
招募中
3 期
Sinus lift surgery with Dental Implants using Rosuvastatin and I-PRFCTRI/2022/08/044627Dr Lahari Buggapati
招募中
不适用
Efficacy of rosuvastatin for the treatment of Non-alcoholic fatty liver disease with hyperlipidemiaon-alcoholic fatty liver disease with hypercholesterolemiaJPRN-UMIN000008075Juntendo University School of Medicine25
进行中（未招募）
不适用
The efficacy and safety of a medicine containing the active substance rosuvastatiPatients with primary hypercholesterolemia and mixed dyslipidemia (type IIb)MedDRA version: 14.1Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10071235Term: Combined hyperlipidemiaSystem Organ Class: 100000004861EUCTR2012-004799-21-CZKRKA CR, s. r. o.540